上海洗霸科技股份有限公司 2025年第一次临时股东大会决议公告 证券代码：603200 证券简称：上海洗霸 公告编号：2025-028 本次会议的召集、召开、表决方式符合《中华人民共和国公司法》《上海洗 霸科技股份有限公司章程》等法律法规和制度的规定。 (五) 公司董事、监事和董事会秘书的出席情况 1、公司在任董事7人，出席7人； 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 227 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 85,265,599 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 48.5899 | | 份总数的比例（%） | | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议采取现场投票与网络投票相结合的方式召开，会议由公司董事会召 集。公司董事长王炜先生因公未能亲自出席本次会议，经半数以上公司董事共同 ...

北京市金杜律师事务所上海分所 关于上海洗霸科技股份有限公司 2025 年第一次临时股东大会之法律意见书 致：上海洗霸科技股份有限公司 北京市金杜律师事务所上海分所（以下简称本所）接受上海洗霸科技股份有 限公司（以下简称公司或上海洗霸）委托，根据《中华人民共和国证券法》（以 下简称《证券法》）、《中华人民共和国公司法》（以下简称《公司法》）、中国证券 监督管理委员会（以下简称中国证监会）《上市公司股东会规则》（以下简称《股 东会规则》）等中华人民共和国境内（以下简称中国境内，为本法律意见书之目 的，不包括中国香港特别行政区、中国澳门特别行政区和中国台湾地区）现行有 效的法律、行政法规、规章和规范性文件和现行有效的公司章程有关规定，指派 律师出席了公司于 2025 年 5 月 26 日召开的 2025 年第一次临时股东大会（以下 简称本次股东大会），并就本次股东大会相关事项出具本法律意见书。 为出具本法律意见书，本所律师审查了公司提供的以下文件，包括但不限于： 1. 经公司 2024 年第二次临时股东大会审议通过的《上海洗霸科技股份有限 公司章程》（以下简称《公司章程》）； 2. 公司 2025 年 5 月 10 ...

Group 1 - The China Automotive Engineering Society released the "Full Solid-State Battery Determination Method" standard, clarifying the definition of solid-state batteries and addressing industry ambiguities and testing method deficiencies [1] - Solid-state batteries offer advantages such as higher safety, energy density, cycle life, mechanical strength, wider temperature adaptability, and material selection, with high safety and capacity being core benefits [1] - Beneficiary companies in the materials sector include CATL, BYD, Yiwei Lithium Energy, Penghui Energy, Tiannai Technology, Xiamen Tungsten, and others [1] Group 2 - The industrialization of solid-state batteries is accelerating, with a focus on the sulfide route in the materials sector and key incremental developments in the equipment sector related to "dry," "press," and "stack" processes [2] - In the front-end segment, dry electrode equipment and solid electrolyte dry film forming equipment are expected to gradually replace traditional wet equipment [2] - The solid-state battery production process requires significantly higher pressure during formation, leading to increased demand for high-pressure formation equipment [2]

Meeting Overview - The annual general meeting of Shanghai Xiba Technology Co., Ltd. was held on May 22, 2025, at the Baishu Building, Shanghai [1] - The meeting was conducted with a combination of on-site and online voting, presided over by the chairman Wang Wei [1] Attendance - All 7 current directors attended the meeting, while 2 out of 3 supervisors were present, with one supervisor absent due to work commitments [2] - The company secretary Wang Shanjiong also attended the meeting [2] Resolutions Passed - The following resolutions were approved during the meeting: 1. 2024 Annual Work Report of the Board [3] 2. 2024 Annual Work Report of the Supervisory Board [3] 3. 2024 Annual Report and Summary [4] 4. 2024 Financial Settlement Report [4] 5. 2025 Financial Budget Proposal [4] 6. 2024 Profit Distribution Proposal [4] 7. 2025 Non-Independent Director Remuneration Proposal [4] 8. 2025 Independent Director Remuneration Proposal [4] 9. 2025 Supervisor Remuneration Proposal [4] 10. Reappointment of the auditing firm for 2025 [5] 11. Proposal for comprehensive credit facilities from banks for 2025 [5] Voting and Legal Compliance - All resolutions were ordinary resolutions requiring more than half of the voting rights held by attending shareholders for approval [5] - Related shareholders abstained from voting on certain proposals, ensuring compliance with legal and regulatory requirements [5] - The meeting was witnessed by lawyers from Beijing King & Wood Mallesons Shanghai Office, confirming that the meeting's procedures and voting results were legally valid [6]

为出具本法律意见书，本所律师审查了公司提供的以下文件，包括但不限于： 1. 经公司 2024 年第二次临时股东大会审议通过的《上海洗霸科技股份有限 公司章程》（以下简称《公司章程》）； 2. 公司 2025 年 4 月 29 日刊登于上海证券交易所网站的《上海洗霸科技股 份有限公司第五届董事会第十四次会议决议公告》《上海洗霸科技股份 有限公司第五届监事会第十一次会议决议公告》； 3. 公司 2025 年 4 月 29 日刊登于上海证券交易所网站的《上海洗霸科技股 份有限公司关于召开 2024 年年度股东大会的通知》（以下简称《2024 年 度股东大会通知》）； 4. 公司本次股东大会股权登记日的股东名册； 5. 出席现场会议的股东及其他人员的到会登记记录及凭证资料； 6. 上证所信息网络有限公司提供的本次股东大会网络投票情况的统计结果； 7. 公司本次股东大会议案及涉及相关议案内容的公告等文件； 北京市金杜律师事务所上海分所 关于上海洗霸科技股份有限公司 2024 年年度股东大会之法律意见书 致：上海洗霸科技股份有限公司 北京市金杜律师事务所上海分所（以下简称本所）接受上海洗霸科技股份有 限公司（以下简称公司 ...

证券代码：603200 证券简称：上海洗霸 公告编号：2025-027 上海洗霸科技股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 表决情况： | 股东类型 | 同意 | | 反对 | | 弃权 | | | --- | --- | --- | --- | --- | --- | --- | | | 票数 | 比例（%） | 票数 | 比例 | 票数 | 比例 | | | | | | （%） | | （%） | | A 股 | 84,999,633 | 99.9554 | 33,300 | 0.0392 | 4,645 | 0.0055 | 2、 议案名称：《关于监事会 2024 年度工作报告的议案》 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 192 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 85,037,578 | | 3、出席会议的股东所持有表决权股份数占公司有表决权 ...

Group 1 - Solid-state battery concept stocks have been declining, with Ningxin New Materials and Lingge Technology dropping over 10% [1] - Other companies such as Wuhan Land Electric, Honggong Technology, Liwang Co., Lingpai Technology, Naconor, Jinyinhai, Liyuanheng, Betterray, and Shanghai Xiba have also seen declines of over 5% [1]

Key Points - Vanke A has signed a supplementary agreement with Shenzhen Metro Group for a loan of up to 4.2 billion yuan, with a pledge of up to 6 billion yuan in shares of its subsidiary, Wanwu Cloud [3] - Heng Rui Pharmaceutical has set the final price for its H-share issuance at 44.05 HKD per share, with plans to list on the Hong Kong Stock Exchange on May 23, 2025 [4] - Wan Dong Medical has elected Ma Chibing as the new chairman after Hu Ziqiang resigned from the position [5] - Tianqi Mould has confirmed that there are no undisclosed significant matters amid ongoing major asset restructuring [6] - Zhejiang Rongtai plans to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - ST Mingcheng intends to publicly transfer 45% of its subsidiary, Time Media, which will no longer be included in the consolidated financial statements [8] - Shanghai Xiba plans to purchase patent assets for 2 million yuan and 500,000 yuan, and establish subsidiaries to promote the commercialization of new technologies [9] - Jushen Co. has received a total of 95.7 million yuan in dividends from its six wholly-owned subsidiaries [10] - ST Asia Pacific has confirmed no undisclosed significant matters or ongoing major plans [11] - Tianrong Tianyu's controlling shareholder's agreement will not be renewed after its expiration [12] - Wangzi New Materials has stated that its energy storage capacitor business is minimal and will not significantly impact its performance [13] - Nanjing Port has clarified that its foreign trade container business does not have direct routes to the U.S. [14] - Jinlongyu has indicated that its solid-state battery business has not yet formed stable long-term revenue [15] - Tianzhihang's subsidiary plans to raise capital by introducing investors [16] - State Grid Information plans to acquire 100% of Yili Technology for 1.853 billion yuan, enhancing its revenue and profit [17] - ST Nongsang will remove its delisting risk warning starting May 23 [18] - Yipin Hong has stated that its innovative drug AR882 has not yet been launched and will not significantly impact recent performance [19] - Huanrui Century has announced a performance compensation plan requiring original shareholders to compensate 116 million shares [20] - Huaren Health plans to acquire stakes in three pharmaceutical chain companies for a total of 3.282 billion yuan [21][22] - Hongming Co. is planning to acquire 83% of Shenzhen Chisu for 1.51 billion yuan [23] - Aishida intends to acquire an additional 7% stake in its subsidiary Qianjiang Robot for 13.09 million yuan [24] - Dasheng Intelligent has signed a contract worth 11.5 million yuan for a high-efficiency machine room project [25] - Jinggu Co. has received a notice to supply wheels for a major global automaker, with expected sales of approximately 158 million USD over ten years [26] - Pingzhi Information has signed a framework agreement with China Mobile for antenna products worth up to 13.01 million yuan [27] - Shanghai Laishi's controlling shareholder plans to increase its stake by 250 million to 500 million yuan [28] - Qixia Construction's shareholder plans to reduce its stake by up to 3% [29] - Sichuan Gold's major shareholders plan to reduce their stakes by up to 5.5% [30] - Qingyun Technology's shareholders plan to reduce their stakes by up to 4.5% [31] - Rhein Biological's directors plan to reduce their stakes by up to 0.14% [32] - Qingmu Technology's shareholder plans to reduce its stake by up to 3% [33] - Sanrenxing's employee shareholding platform plans to reduce its stake by up to 3% [34][35] - Juzhi Technology's director plans to reduce his stake by up to 40,000 shares [36] - Jingwang Electronics' major shareholders plan to reduce their stakes by up to 2.99% [37] - Jujiao Co. plans to reduce its stake by up to 2.6% [38] - Xiyu Tourism's major shareholder plans to reduce its stake by up to 3% [39]

Core Viewpoint - Shanghai Xiba plans to acquire patents and establish two holding subsidiaries to promote the industrialization of high-energy hydrogen-electric hybrid power systems and special solid-state lithium-ion battery technologies, enhancing its position in the new energy sector [1][2]. Summary by Sections Patent Acquisition - Shanghai Xiba will purchase four invention patents and one utility model patent from the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, for a total of 25 million yuan (approximately 3.5 million USD) [1]. Subsidiary Establishment - The company intends to set up two holding subsidiaries with a registered capital of 10 million yuan (approximately 1.4 million USD) each, in collaboration with its core technology and management teams [1][2]. Business Strategy - The establishment of these subsidiaries aligns with the company's business and strategic planning, aiming to integrate technical advantages and resources from partners to enhance its capabilities and competitiveness in the new energy sector [2]. Current Business Context - Shanghai Xiba's main business involves customized water treatment chemicals and equipment, with a recent focus on advanced materials for solid-state batteries [3]. The company has completed the design of high-energy soft-pack lithium-ion solid-state batteries, which are now in small-scale production [3]. Financial Performance - In Q1 2025, the company reported a significant decline in net profit by 51% year-on-year to 9.83 million yuan (approximately 1.4 million USD), with a 17% drop in revenue, primarily due to the lack of high-margin projects compared to the previous year [4]. Future Outlook - Despite substantial investments in advanced materials, the business has not yet generated stable, large-scale revenue [5]. The company plans to focus on its core water treatment services while gradually reducing its involvement in engineering construction, aiming to develop a second growth curve in the new energy advanced materials sector [4].

Group 1 - Huiyu Pharmaceutical's subsidiary received drug registration certificate for Carboxymethyl Sodium Injection, which is used for treating bleeding diseases in various medical fields [1] - Baihe Co., Ltd. announced a plan for a director to reduce holdings by up to 424,000 shares, representing 0.6625% of the total share capital [1] - Kingood Co., Ltd. received a notification from a global leading automaker for a wheel project, expected to start mass production in 2026 with a lifecycle of 10 years [1][2] Group 2 - Wanhua Chemical plans to repurchase shares worth between 300 million and 500 million yuan, with a maximum repurchase price of 99.36 yuan per share [2] - Warner Pharmaceutical's subsidiary received approval for Acetylcysteine raw material drug, primarily used for treating respiratory diseases [3] - ST Mingcheng plans to publicly transfer 45% equity of its subsidiary, aiming to optimize asset structure [4] Group 3 - Qixia Construction announced a plan to reduce up to 31.5 million shares, accounting for 3% of total share capital [5][6] - Zhejiang Rongtai intends to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - Yuandong Biological received drug registration for Chloral Hydrate Enema, used for sedation and seizure control in children [9] Group 4 - Jiemai Technology's subsidiary signed a strategic cooperation agreement with a solid-state battery company to produce high-safety composite conductive materials [10] - Xianju Pharmaceutical received drug registration for Progesterone Soft Capsules, used for treating functional disorders due to luteal deficiency [11] - Lanhua Kecai's subsidiary reported a temporary production halt, with the resumption date yet to be determined [13] Group 5 - Sinopharm Modern's subsidiary received drug registration for Tocilizumab Tablets, used for treating rheumatoid arthritis and other conditions [15] - Shanghai Bank announced the resignation of its vice president due to organizational adjustments [17] - Shanghai Pharmaceutical's Ephedrine Injection passed the consistency evaluation for generic drugs [19] Group 6 - Rundu Co., Ltd. received drug registration for Amlodipine and Olmesartan Tablets, aimed at treating hypertension [21] - Zhong'an Technology announced that 61 million shares held by its controlling shareholder will be auctioned [23] - Shanghai Washba plans to purchase patent assets and establish two subsidiaries focused on hydrogen energy and solid-state battery technologies [25] Group 7 - Nuo Cheng Jianhua's new drug Tafasitamab received approval for treating relapsed/refractory diffuse large B-cell lymphoma [26] - Benli Technology plans to use up to 200 million yuan of idle funds for cash management and financial investments [28] - Taiji Co., Ltd. intends to use 60 million yuan of idle funds to purchase financial products [29] Group 8 - Haishi Co. announced that its innovative drug Anreke Fen Injection received drug registration for treating postoperative pain [32] - Yulong Co. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [36] - Weifu High-Tech plans to establish a joint venture with Shanghai Baolong Automotive Technology [38] Group 9 - Xichang Electric Power expects a net profit reduction of approximately 5.4 million yuan due to adjustments in the time-of-use electricity pricing mechanism [39] - Alter signed a contract worth 6.8 billion yen for the development and procurement of large truck EV kits [41] - Zhonglian Heavy Industry plans to acquire controlling stakes in its financing leasing subsidiary through public bidding [42] Group 10 - Sanyou Medical's executive plans to reduce holdings by up to 1.44% of the company's shares [43] - Hangyang Co. plans to establish a subsidiary for large modular cryogenic equipment manufacturing with an estimated investment of 557 million yuan [44] - FAW Fuwi received a notification for a dashboard project from a well-known new energy brand, with total sales expected to reach 1.06 billion yuan [45]